Canaccord Genuity Group Issues Positive Forecast for Clover Health Investments (NASDAQ:CLOV) Stock Price
Clover Health Investments (NASDAQ:CLOV – Get Free Report) had its target price increased by stock analysts at Canaccord Genuity Group from $4.20 to $5.50 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target indicates a potential upside of 22.22% from the […]
21 Jul 12:06 · The Markets Daily